News Harvard Study Finds No Link Between Clinical Exams and MRIs in Some MS Patients Harvard Study Finds No Link Between Clinical Exams and MRIs in Some MS Patients by Jose Marques Lopes, PhD | June 21, 2017 Share this article: Share article via email Copy article link Physical disability may have no link toĀ brain lesion volume in some patients with multiple sclerosis (MS),Ā concludes a recent study led by Dr.Ā Rohit Bakshi, aĀ neurology and radiology professor atĀ Harvard Medical School. The study, āCharacterizing Clinical and MRI Dissociation in Patients with Multiple Sclerosis,ā appearedĀ in the Journal of Neuroimaging. MS patients manifest their disease in many forms, rangingĀ from limited disability many years after diagnosis to severe physical limitations early in MS development. Clinical exams and a brain magnetic resonance imaging (MRI) scan are two common strategies to determine disease severity in MS. Although the results of assessing disease severity using both measures are similar in most patients, some patients show clinical/MRI dissociation, complicating their prognosis. Bakshi’s studyĀ enrolled 533 MS patients from a comprehensive care center with a concurrent brain MRI, spinal cord MRI, clinical examination and patient reported outcomes. ResearchersĀ classified the patients into three groups based on a disability scale and the volume of cerebral T2 hyperintense lesions (T2LV), which represent inflammatory events found in brain scans that can be related to MS. The first group included 22 patients with low lesion load/high disability (LL/HD), and the second group had 50 patients with high lesion load/low disability (HL/LD). A third group included patients classified as not dissociated. ResearchersĀ found that 13.5 percent of the patients had clinical/MRI dissociation. Subjects in the LL/HD group were more likely to have a progressive form of MS, more cervical spinal cord lesions and lower physical quality of life. The authors say this may be related to the concentration of lesions in the spinal cord rather than the brain, leading to poorer outcomes. Future work should also determine the importance of spinal cord atrophy. Conversely, subjects in the HL/LD group had significantly more gadolinium-enhancing lesions, which are typically active and correlate with inflammatory processes. Interestingly, an explanation for having greater lesion load while showing low clinical disability is the presence of ācompensatory mechanisms that allow the patient to retain physical functioning despite a large amount of structural damage,ā authors wrote. Of note, although the differences in cognition did not reach significance, the authors speculate that using larger sample sizes and a more comprehensive test battery may show that the patients in the HL/LD group have significant cognitive impairment. “Dissociation may occur between physical disability and cerebral lesion volume in either direction in patients with MS. Type of MS, brain atrophy, and spinal cord lesions may help to bridge this dissociation,ā concludedĀ Bakshi, who is alsoĀ a senior neurologist at Brigham and Women’s HospitalĀ and director of the Laboratory for Neuroimaging Research at Boston’sĀ Partners Multiple Sclerosis Center, Print This Page About the Author Jose Marques Lopes, PhD JosĆ© holds a PhD in neuroscience from the University of Porto, Portugal. After postdocs at Weill Connell Medicine and Western University, where he studied the processes driving hypertension and Alzheimerās disease, he moved on in 2016 to a career in science writing and communication. JosĆ© is the author of several peer-reviewed papers and a book chapter and has presented his research in numerous international meetings. Tags disability, lesions, MRI, quality of life
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Long-term data support early Kesimpta start in relapsing MS
April 18, 2024 Columns by Benjamin Hofmeister Learning how to write a ‘SOAP’ note feels different after an MS diagnosis
April 18, 2024 News by Marisa Wexler, MS AAN 2024: Sustained myelin, nerve cell gains with long-term CNM-Au8